The therapeutic benefit of epicatechin in induced cytokine storm in mice
Abstract
Background: Cytokine storm is an unbalanced systemic inflammatory response defined by the release of massive quantities of proinflammatory cytokines and chemokines that damage tissue and lead to multiple organ failure. Several compounds are being investigated as potential modulators of excessive cytokine release that leads to systemic malfunction. This study aims to assess the therapeutic efficacy of Epicatechin in Swiss albino male mice suffering from cytokine storm induced by lipopolysaccharides (LPS).
Methods: Fifty healthy male Swiss albino mice were used for the animal experiment. The mice were separated into 5 groups, each group containing 10 mice. The study involved various groups, including control (AH), lipopolysaccharides (LPS), dimethyl sulfoxide (DMSO), methylprednisolone (MT) and epicatechin (ET), which received a single injection of 5 mg/kg lipopolysaccharide solution, except the AH group. The groups were injected with various treatments. First, a 1% dimethyl sulfoxide (DMSO) solution was injected into the DMSO group. 50 mg/kg methylprednisolone solution was injected into the MT group. 25 mg/kg epicatechin solution was injected into the ET group. This experiment was conducted till day 8; on the 8th day, certain cytokine storm-related parameters were studied, which included the serum IL-6, TNF-α and IL-1β levels, along with lung tissue pathological changes.
Results: The treated groups showed a significant decrease in all measured serum cytokine levels, along with improved lung histopathological changes compared to non-treated groups.
Conclusion: Epicatechin effectively reduces all studied serum cytokine levels in mice, thereby mitigating lipopolysaccharide (LPS)-induced cytokine storm and lung injury.
Keywords: 1% DMSO, Lipopolysaccharides, Methylprednisolone, Epicatechin, Cytokines, Cytokine Storm
Full Text:
PDFReferences
Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V. Evolutionary divergence and functions of the human interleukin (IL) gene family. Human Genomics, (2010); 5(2010): 1–26.
Jang DI, Lee AH, Shin HY, Song HR, Park JH, et al. The role of tumor necrosis factor-alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. International Journal of Molecular Sciences, (2021); 22(5): 2719.
Hirano T. IL-6 in inflammation, autoimmunity, and cancer. International Immunology, (2021); 33(3): 127–148.
Zalinger ZB, Elliott R, Weiss SR. Role of the inflammasome-related cytokines IL-1 and IL-18 during infection with murine coronavirus. Journal of Neurovirology, (2017); 23(2017): 845–854.
Wang Y, Che M, Xin J, Zheng Z, Li J, et al. The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomedicine & Pharmacotherapy, (2020); 131(2020): 110660.
Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: The anger of inflammation. Cytokine, (2020); 133(2020): 155151.
Wan J, Zhang L, Ruan Z. Dietary Supplementation with Epicatechin Improves Intestinal Barrier Integrity in Mice. Foods, (2022); 11(20): 3301.
Shariati S, Kalantar H, Pashmforoosh M, Mansouri E, Khodayar MJ. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice. Biomedicine & Pharmacotherapy, (2019); 114(2019): 108776.
Xing J, Yu Z, Zhang X, Li W, Gao D, et al. Epicatechin alleviates inflammation in lipopolysaccharide-induced acute lung injury in mice by inhibiting the p38 MAPK signaling pathway. International Immunopharmacology, (2019); 66(2019): 146–153.
Wu H, Xie Y, Xu Y, Hu Z, Wan X, et al. Protective effect of Epicatechin on APAP-induced acute liver injury of mice through anti-inflammation and apoptosis inhibition. Natural Product Research, (2020); 34(6): 855–858.
Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 1978; 129: 1–504. Wiley.
Brodzikowska A, Ciechanowska M, Kopka M, Stachura A, Włodarski PK. Role of lipopolysaccharide, derived from various bacterial species, in pulpitis—A systematic review. Biomolecules, (2022); 12(1): 138.
Abed Mansoor AF, Abu Raghif AR. Attenuated effects of rivastigmine in induced cytokine storm in mice. Journal of Emergency Medicine, Trauma & Acute Care, (2022); 2022(3): 12.
Sahib HB, Kathum OA, Alanee RS, Jawad RA, Al-Shammari AM. The anti‐cytokine storm activity of quercetin zinc and vitamin C complex. Advances in Virology, (2022); 2022(1): 1575605.
Skrzypczak-Wiercioch A, Sałat K. Lipopolysaccharide-induced model of neuroinflammation: Mechanisms of action, research application and future directions for its use. Molecules, (2022); 27(17): 5481.
Prince PD, Fischerman L, Toblli JE, Fraga CG, Galleano M. LPS-induced renal inflammation is prevented by (−)-Epicatechin in rats. Redox Biology, (2017); 11(2017): 342–349.
Li Z, Fu X, Fan Y, Zhao C, Wang Q, et al. Effect of Epicatechin on inflammatory cytokines and MAPK/NF-κB signaling pathway in lipopolysaccharide-induced acute lung injury of BALB/c mice. General Physiology and Biophysics, (2022); 41(4): 299–308.
Wu C, Li F, Zhang X, Xu W, Wang Y, et al. (−)-Epicatechin ameliorates monosodium urate-induced acute gouty arthritis through inhibiting NLRP3 inflammasome and the NF-κB signaling pathway. Frontiers in Pharmacology, (2022); 13(2022): 799552.
Leszczyńska K, Jakubczyk D, Górska S. The NLRP3 inflammasome as a new target in respiratory disorders treatment. Frontiers in Immunology, (2022); 13(2022): 1006654.
Tian X, Xue Y, Xie G, Zhou Y, Xiao H, et al. (−)-Epicatechin ameliorates cigarette smoke-induced lung inflammation via inhibiting ROS/NLRP3 inflammasome pathway in rats with COPD. Toxicology and Applied Pharmacology, (2021); 429(2021): 115674.
Cho JS, Han IH, Lee HR, Lee HM. Prostaglandin E2 induces IL-6 and IL-8 production by the EP receptors/Akt/NF-κB pathways in nasal polyp-derived fibroblasts. Allergy, Asthma & Immunology Research, (2014); 6(5): 449–457.
Zasłona Z, Pålsson-McDermott EM, Menon D, Haneklaus M, Flis E, et al. The induction of pro–IL-1β by lipopolysaccharide requires endogenous prostaglandin E2 production. The Journal of Immunology, (2017); 198(9): 3558–3564.
Lewis A, Elks PM. Hypoxia induces macrophage TNFα expression via cyclooxygenase and prostaglandin E2 in vivo. Frontiers in Immunology, (2019); 10(2019): 2321.
Wang H, Cao Z. Anti-inflammatory effects of (−)-Epicatechin in lipopolysaccharide-stimulated RAW 264.7 macrophages. Tropical Journal of Pharmaceutical Research, (2014); 13(9): 1415–1419.
Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. The American Journal of Emergency Medicine, (2008); 26(6): 711–715.
Ye R, Liu Z. ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway. Experimental and Molecular Pathology, (2020); 113(2020): 104350.
Xing J, Yu Z, Zhang X, Li W, Gao D, et al. Epicatechin alleviates inflammation in lipopolysaccharide-induced acute lung injury in mice by inhibiting the p38 MAPK signaling pathway. International Immunopharmacology, (2019); 66(2019): 146–153.
Dickerhof N, Magon NJ, Tyndall JD, Kettle AJ, Hampton MB. Potent inhibition of macrophage migration inhibitory factor (MIF) by myeloperoxidase-dependent oxidation of epicatechins. Biochemical Journal, (2014); 462(2): 303–314.
Cilleros DÁ, López-Oliva ME, Martín MÁ, Ramos S. (−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling. Food & Function, (2020); 11(10): 8811–8824.
DOI: http://dx.doi.org/10.62940/als.v12i3.2009
Refbacks
- There are currently no refbacks.